Bram van den Broek

12PUBLICATIONS
93CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.

Muddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam

|Nov 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

Sofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto

|May 31, 2023
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks.

Abdelghani Mazouzi, Sarah C Moser, Federico Abascal

|Oct 28, 2022
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing.

Miguel Vizoso, Colin E J Pritchard, Lorenzo Bombardelli

|Jul 17, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.

Stefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta

Pageof 2